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Legal framework conditions for the reprocessing of
medical devices
RechtlicheRahmenbedingungenzurAufbereitungvonMedizinprodukten
Abstract
The processing of single-use products is permissible pursuant to med-
ical device law. This is apparent both from the wording of the German
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Law on Medical Devices and from the purpose and the objectives un-
derpinning the legislative materials. The prerequisite for processing is,
however, compliance with the the Joint Recommendation of the Com- 1 Healthcaredepartmentatthe
Katholische Hochschule mission for Hospital Hygiene and the Prevention of Infection at the
NRW, Cologne division,
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Robert Koch Institute (RKI) and the Federal Institute for Drugs and
Medical Products (BfArM).
For medical devices in the category “critical C”, the RKI/BfArM-recom-
mendation provides that the processor’s quality management system
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Germany must be certified by a body accredited by the Central Authority of the
Federal States for Health Protection with regard to Medicinal Products
and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz
bei Arzneimitteln und Medizinprodukten, ZLG). The certification must
be carried out in accordance with EN ISO 13485:2003+AC:2007.
On April 4, 2008 the Federal Health Ministry (Bundesministerium für
Gesundheit, BMG) presented a progress report on the processing of
medical devices. The BMG concludes that the legal framework for the
processing of medical devices is sufficient, and that a prohibition on
the processing of single-use products is inappropriate.
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product, DIN EN ISO 13485:2003+AC:2007, Federal Health Ministry,
Central Authority of the Federal States for Health Protection with regard
to Medicinal Products and Medical Devices, accreditation
Zusammenfassung
Die Aufbereitung von Einmalprodukten ist medizinprodukterechtlich
zulässig. Das ergibt sich sowohl aus dem Wortlaut des Medizinproduk-
terechtsalsauchausSinnundZweckundausdenGesetzesmaterialien.
Voraussetzung ist allerdings die Einhaltung der gemeinsamen Empfeh-
lungderKommissionfürKrankenhaushygieneundInfektionsprävention
desRobertKoch-Instituts(RKI)unddesBundesinstitutsfürArzneimittel
und Medizinprodukte (BfArM).
Für Medizinprodukte der Kategorie „kritisch C“ sieht die RKI/BfArM-
Empfehlungvor,dassdasQualitätsmanagementsystemdesAufbereiters
durch eine von der Zentralstelle der Länder für Gesundheitsschutz bei
ArzneimittelnundMedizinprodukte(ZLG)akkreditierteStellezertifiziert
sein muss. Diese Zertifizierung hat nach DIN EN ISO 13485:2003+AC:
2007 zu erfolgen.
Das Bundesministerium für Gesundheit (BMG) hat am 04.04.2008
einenErfahrungsberichtzurAufbereitungvonMedizinproduktenvorge-
legt. Im Ergebnis stellt das BMG fest, dass der Rechtsrahmen für die
Aufbereitung von Medizinprodukten ausreichend und ein Verbot der
Aufbereitung von Einmalprodukten nicht sachdienlich sei.
Schlüsselwörter: Aufbereitung, Medizinprodukt, Zertifizierung,
Einmalprodukt,DINENISO13485:2003+AC:2007,Bundesministerium
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Introduction
The term reprocessing is defined in § 3 No. 14 MPG
(Medizinproduktegesetz) as follows: The reprocessing of
medical devices intended to be applied semi-sterile or
sterile, is the cleaning, disinfection and sterilisation, in-
cluding the processes connected therewith, as well as
the testing and restoration of technical-functional safety,
following their use for the purpose of renewed use.
It clearly follows from this definition that the term “repro-
cessing” refers not only to the cleaning, disinfection and
sterilisation of medical devices. Rather, the technical-
functional safety must also be tested and, if necessary,
restored. Reprocessed medical devices must offer the
same standard of safety as a new product in terms of
theirmaterialcharacteristics,theirfunctions(e.g.record-
ing, cutting, coagulating) etc.
At the same time, the legislator clarifies in § 4 para. 1
MPBetreibV(Medizinproduktebetreiberverordnung)that,
in addition to servicing, inspection and repair, repro-
cessingconstitutesafourthsub-categoryofmaintenance,
and is thus recognised as another form of operation of
medical devices.
There are currently approximately 400,000 medical
devices on the market. A large number of these articles
can – following appropriate professional reprocessing –
be re-used in medical treatment.
Without a doubt, it is particularly health economics argu-
ments that influence the decision as to whether to repro-
cess medical devices for re-use. The basic rule here is
that reprocessing – regardless of whether a medical
device is declared for single use or for repeated use – is
even more worthwhile the greater the input of materials
andresourcesrequiredinthemanufactureofthemedical
device in question.
This economic interest is, however, limited by the need
to protect patients against functional, immunological,
toxicologicalorhygienicimpairmentthroughreprocessed
medical devices. In healthcare practice, this economic/
legal conflict initially triggers questions in particular with
regard to the regulatory aspects of Medical Device Law.
However,medicalliabilitylawisalsoincreasinginimport-
ance in this area.
Reprocessing requirements
pursuant to medical device law
The regulatory requirements for reprocessing medical
devices are set forth in the law on medical devices. The
basic norm here is the German Act on Medical Devices
(Medizinproduktegesetz, hereinafter MPG), which trans-
posedDirective90/385/EEC(activeimplantablemedical
devices),98/79/EC(in-vitro-diagnostics)and93/42/EEC
(other medical devices) into German law.
The general provisions of the MPG are governed in detail
inanumberofordinances,e.g.TheMedicalDeviceOper-
ators Ordinance (Medizinproduktebetreiberverordnung,
hereinafter MPBetreibV).
The requisite reprocessing quality is defined in § 4 para.
2 sentence 1 MPBetreibV.
The reprocessing of medical devices intended to be ap-
plied semi-sterile or sterile is to be carried out taking into
accountthemanufacturer’sspecificationsusingsuitable
validated procedures, such that the success of these
procedures can be verifiably ensured and the safety and
healthofpatients,usersorthirdpartiesisnotputatrisk.
§ 4 para. 2 sentence 3 MPBetreibV governs when proper
reprocessing, as defined in § 4 para. 2 sentence 1
MPBetreibV, is given:
Proper reprocessing pursuant to sentence 1 is assumed
if the Joint Recommendation of the Commission for
Hospital Hygiene and the Prevention of Infection at the
Robert Koch Institute and the Federal Institute for Drugs
and Medical Devices concerning Hygiene Requirements
when Reprocessing Medical Devices is observed.
In terms of the law, a rule of assumption, which can be
refuted in individual cases, was chosen ([1] Vol. 3,
Chapter 8.4, 12f). If an operator or, as the case may be,
an external processor (service provider), carries out the
reprocessing in accordance with the Joint Recommenda-
tion of the Commission for Hospital Hygiene and the
Prevention of Infection at the Robert Koch Institute (RKI)
and the Federal Institute for Drugs and Medical Products
(BfArM) (hereinafter: joint RKI and BfArM Recommenda-
tion [2]), then it shall initially be assumed that the repro-
cessing was carried out properly.
The Joint RKI and BfArM
Recommendation
The Joint RKI and BfArM Recommendation governs the
detailsconcerningthehygienerequirementswhenrepro-
cessingmedicaldevices.Medicaldevicesaredividedinto
various categories of risk on the basis of the type of ap-
plication, and the risk involved:
• non-critical medical devices (e.g. ECG electrodes),
• semi-critical medical devices (e.g. endoscope),
• critical medical devices.
Pursuant to the Joint RKI and BfArM Recommendation,
critical medical devices are devices used for the applica-
tion of blood, blood products and other sterile medicinal
products and medical devices that penetrate the skin or
mucous membrane and thereby come into contact with
blood, internal tissues or organs, including wounds.
In turn, the critical medical devices are divided into sub-
categories:
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e.g. hook retractors),
• critical B (with more stringent reprocessing require-
ments, e.g. MIC trocars),
• critical C (with particularly stringent reprocessing re-
quirements, e.g. heart catheters).
The Joint RKI and BfArM Recommendation provides with
regard to medical devices belonging to the category
“critical C”, that the reprocessor’s quality management
system must be certified by a body accredited by the
Central Authority of the Länder for Health Protection with
regard to Medicinal Products and Medical Devices (Zent-
ralstellederLänderfürGesundheitsschutzbeiArzneimit-
teln und Medizinprodukte, ZLG; named body pursuant to
§ 20 para. 1 MPG). This certification must be carried out
in accordance with DIN EN ISO 13485:2003+AC:2007,
i.e.inaccordancewiththeonlyDINnormcurrentlyapplic-
able in the area of Quality Management Systems of
medical device reprocessing.
Accreditation and certification
Pursuant to the Joint RKI and BfArM Recommendation,
not every body can certify the quality management sys-
tems for the reprocessing of medical devices belonging
to the category “critical C”. Instead, a designated body
(explanation: named bodies are independent certifying
offices organised under private law. They are, however,
subject to state supervision and must be accredited by
theZLG,forexample.Thesuitabilityasadesignatedbody
isexaminedandascertainedintheaccreditationproceed-
ings) must be specifically accredited by the ZLG for this
purpose. In contrast to the ZLG, the Central Authority of
theLänderforSafetyTechnology(ZentralstellederLänder
fürSicherheitstechnik,ZLS)doesnotcertifyanyappointed
offices for the reprocessing of medical devices.
AsperMay1,2008thefollowingdesignatedbodieshave
been accredited by the ZLG (http://www.zlg.de) for this
purpose:
• DEKRA Certification GmbH Stuttgart,
• LGA InterCert Nürnberg,
• TÜV Rheinland Product Safety GmbH Köln,
• MedCert Hamburg.
Finally, it must be pointed out that the certificates issued
by the accredited designated body have a limited applic-
ability – they usually apply for a maximum of five years.
Thiscorrespondswiththeprovisionsin§17para.1MPG.
Reprocessors must, as explained under point 2, prove
theirabilitytoproperlyreprocessmedicaldevicesbelong-
ing to category “critical C” as defined in § 4 MPBetreibV,
bywayofacertificateissuedbyadesignatedbodyaccred-
ited for this purpose by the ZLG.
The quality management system of the company for the
reprocessingofmedicaldevicesbelongingtothecategory
“critical C” is tested in the course of such certification.
This certification relates both to the introduction and to
the maintaining and application of the quality manage-
ment systems.
The certificate is granted for specific groups of medical
devices and products. The operator of medical devices
is thus able, with the help of the certificate, to examine
in each case whether the contractor is able to properly
reprocessthemedicaldevicessubmittedbytheoperator
for reprocessing.
Legalpermissibilityofreprocessing
single-use products pursuant to
medical device law
NeithertheMPGnortheordinancesenactedonthebasis
thereof expressly prohibit the reprocessing of single-use
products. Nevertheless, the reprocessing of single-use
products is disputed in the literature. This is a result of
the structure of the law: pursuant to § 2 para. 1
MPBetreibV, medical devices may only be constructed,
operated, used and maintained in accordance with their
specifications.
The central issue in this context is whether the manufac-
turer’sdesignationas“single-usemedicaldevice”belongs
to the specification or whether this is merely a restriction
on the use, or a definition of a term on the part of the
manufacturer.
According to one view represented in the literature, the
“single-use”designationispartofthespecification,since
the specification does not depend only on the relevant
characteristics in the medical device definition set forth
in § 3 No. 1 MPG. Instead, the manufacturer would have
to define additional purposes, e.g. with regard to the
classification of the medical device. This view would cor-
respond with an interpretation in line with the directive,
taking into account the safety concept on which medical
device law is based [3]. Were one to follow this under-
standing, the reprocessing of single-use products would
be contrary to their purpose, and, thus, prohibited.
According to the opposing view, however, only the char-
acteristicsofamedicaldevicespecifiedin§3No.1MPG
belong to the specifications. This would result from the
definition of specifications in § 3 No. 10 MPG, which
referstotheuseoftheproductandthereforeconstitutes
a reference exclusively to the definitions in § 3 No. 1
MPG. It is argued that with the specifications the manu-
facturer could only pursue goals that are designated in
the definition of medical devices contained in § 3 No. 1
MPG. All further declarations are solely for the purpose
of labelling ([4], [5] § 9, margin note 56).
Thelatteropinionshouldbeconfirmed,sincetheexpress
emphasis of the intended use in the definition set forth
in § 3 No. 10 MPG constitutes a pretty clear reference to
thestatementsinthemedicaldevicedefinitioncontained
in § 3 No. 1 MPG. This does not, however, include the
designation “single-use product”. The safety concept of
medical device law does not demand the prohibition of
reprocessingofsingle-useproductseither.Whatisimport-
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when reprocessing, which is secured by way of the provi-
sions of the MPBetreibV.
Ultimatelythepurposeofthenorm,whichcanbederived
from the legislative intent and historic interpretation,
supports the permissibility of reprocessing single-use
products.
The proposed resolution of the Health Committee on the
2
nd Act to Amend the MPG states that the amendment
shall serve to remove the legal uncertainties in the area
of the reprocessing of single-use products. It states that,
in the interests of consumer protection, the Federal
MinistryforHealthiscalledupontointroduceappropriate
supervision of the reprocessing of single-use products
[6]. Thus, the legislator is obviously proceeding on the
basis that the reprocessing of single-use products is
permissible, and wanted to ensure in the course of the
2
nd Act to Amend the MPG that this reprocessing attains
a high qualitative standard by way of appropriate super-
vision.
The Federal government’s answer to a parliamentary
question regarding the reprocessing of single-use
products leads to the same outcome. According to the
unequivocal answer, the reprocessing of single-use
productsisnotprohibited.Thereprocessingrequirements
do not differentiate between single-use and multi-use
products [7].
So, the reprocessing of single-use products is legally
permissible. Citing the legislative purpose, the higher
courts seconded this outcome in a decision [8].
Medical device law from the point
of view of liability law
As explained under point 6, the reprocessing of medical
devices that are intended to be applied semi-sterile or
sterileis,althoughitentailsmorestringentrequirements,
permissible under European and German Federal Law.
However, this legislative system of values does not re-
lease the manufacturers, nor the professional operators
of medical devices, from their liability under liability law
fordamageresultingfromtheuseofincorrectlyprocessed
medical devices.
Thecivilandcriminallawresponsibilityofamanufacturer
of medical devices, or that of his authorised agents in
the course of the first placing on the market of a medical
deviceforfaultsintheconstruction,themanufactureand
the instructions, as well as for product supervision
measures that were disregarded, was expressly clarified
with the entry into force of the 2
nd Act to Amend the MPG
onJanuary1,2002through§6para.4togetherwith§5
MPG: pursuant to this, the operators of medical devices
are obligated to monitor compliance and correct imple-
mentation of the provisions of the MPG and the
MPBetreibV by way of organisational and technical
measures.
Pursuant to § 4 para. 2 sentence 1 MPBetreibV, the re-
processing of medical devices intended to be applied
semi-sterile or sterile is to be carried out taking into ac-
count the manufacturer’s specifications using suitable
procedures such that the success of this procedure can
be verifiably ensured and the safety and health of pa-
tients,usersandthirdpartiesisnotputatrisk(indistinc-
tion the reprocessing of medical devices that are not ap-
plied sterile usually amounts to nothing more than the
measures to maintain the normal condition (servicing),
i.e.simplecleaning).AccordingtoadecisionoftheAdmin-
istrative Court Arnsberg it is therefore not sufficient if a
clinic assumes that the medical devices treated in a
steamsteriliseraresterile,withouttherebeingavalidated
procedure [9].
In order to avoid any claim against the operator under li-
ability law, the medical devices must be reprocessed in
accordancewithavalidatedanddocumentedprocedure.
Onlythroughthevalidationofthereprocessingprocedure
arethecorrectparametersdefined,whicharenecessary
in order to prove that the process in question was carried
outinaformthatguaranteeseffectivereprocessing([10]
chapter II 3, § 4, MPBetreibV, Rn. 3).
The subject of a validation procedure must, therefore,
refer to a documented procedure for the performance,
recording and interpretation of the results. This is the
only way that proof can be provided that products of
consistently equal quality can be achieved in a repro-
cessing procedure [9].
The success of the proper reprocessing process is linked
to a decisive degree with the knowledge of the condition
ofamedicaldevice.Itisaboveallthemanufacturerswho
have well-founded expert knowledge of this. On grounds
of patient-protection and for liability law protection, the
operators should therefore request details of the appro-
priate validated reprocessing procedures from the man-
ufacturers.
When a claim is made against an operator of medical
devices under liability law, § 4 para. 2 sentence 3
MPBetreibV plays a central role. As explained under
clause 2b, it is assumed – such assumption being refut-
able – that an operator or an external processor has
carried out the reprocessing correctly if the reprocessing
procedurecomplieswiththeJointRKIandBfArMRecom-
mendation.
Complying with the recommendation does not constitute
a direct statutory obligation, i.e. failure to comply with it
does not lead to any direct punishment of the operator.
However, in the event that a claim is made under liability
law, failure to comply with the recommendation can lead
to an alleviation of the burden of proof on the claimant’s
side. The allocation of the burden of proof in the pa-
tient/operator relationship basically follows the general
rules, pursuant to which the claimant carries the burden
of proof for all conditions establishing his claim.
From the point of view of the law of evidence, this initially
results in a comfortable position for the operator of
medical devices. If, however, the aforementioned recom-
mendations are not observed when reprocessing, then
in the event of an incident the onus of presentation and
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cumbent upon the operator of the medical device.
The reprocessing of medical devices belonging to the
highestriskcategory(criticalC),orofmedicaldevicesfor
which the manufacturer has restricted re-use (single-use
products), constitute a special case. As explained above,
the reprocessing of the aforementioned articles is not
directly or indirectly prohibited at any point in the MPG
or the MPBetreibV. On the contrary – the Federal govern-
ment follows the strategy that it is possible to safely re-
process these medical devices [11].
With regard to the reprocessing too, the quality manage-
ment system set up by the reprocessor must have been
certifiedbyabodyaccreditedbythecompetentauthority.
Inthecaseofsingle-useproducts,forwhich,accordingly,
themanufacturerhasnotprovidedavalidatedprocedure,
itisoftheutmostimportanceforensuringsafetythatthe
reprocessor is able to understand the function and con-
dition of the medical device to be reprocessed.
Only well-founded expert knowledge with regard to the
material characteristics and the technical construction
of a product ensure that an adequate validated repro-
cessing procedure can be developed, implemented and
certified ([10] chapter II 3, § 4 MPBetreibV, margin note
4). If the operator outsources the task of reprocessing
andhasitcarriedoutbyanexternalthirdparty,theselec-
tionofthereprocessorisplacedinhisresponsibility.From
the point of view of an operator of medical devices, it is
thereforeessentialthatavalidatedandverifiedprocedure
be provided when outsourcing the reprocessing.
In this connection, the certification of the processing
company constitutes a milestone in the course of liability
lawriskmanagement,becausethisenablestheoperator
to ensure that the external reprocessor carries out the
reprocessing properly and professionally.
Conclusion
When deciding whether to reprocess medical devices for
the purpose of re-use, the benefits and risks must be
carefully weighed up against each other in the interests
of the efficient development of our healthcare system.
According to the legislator’s intention, when discussing
how to finance the services required pursuant to social
security law, in addition to many economic issues, sus-
tainabilitymustalsobetakenintoaccount,i.e.inaddition
to economic factors, environmental aspects are increas-
ing in importance in the course of the selection of a
medical device. Here, it is the case that reprocessing,
regardless of whether the medical device is declared for
single useor for repeated use, appears even more
worthwhilethegreatertheinputofmaterialandresources
required in the manufacture of the medical device in
question [12].
From the legal point of view, however, this discretion in
the selection is, pursuant to these parameters, limited
by an incontrovertible liability law factor: patient protec-
tion. Consequently, with regard to the reprocessing of
single-useproductsinparticular,itmustbeexaminedfor
each individual product with the greatest degree of care
whetherthematerialcharacteristicsandtheconstruction
of the medical device allow it to be reprocessed, without
this posing a risk to life or limb of the patient.
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